ArticleMethods in molecular biology (Clifton, N.J.)2026
Reimagining the Synthetic Biology DBTL Cycle with Machine Learning.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While progress has been made in developing synthetic regulatory circuits for a variety of applications, circuit engineering remains highly unpredictable due to the inherent complexity of the intracellular medium. With recent advances in high-throughput molecular biology, we are witnessing early progress in the use of ML/AI tools for overcoming this complexity and accelerating circuit engineering. The use of ML/AI for circuit design is not currently limited by a lack of computing power or model architectures-it is held back by the lack of high-quality training datasets. One recently reported pipeline, CLASSIC, is a platform for building expansive circuit libraries via hierarchical DNA assembly, and assaying them using a combination of next-generation long- and short-read sequencing. The development of CLASSIC has not only illuminated best practices for high-throughput data collection and model training but also defined principles for incorporating ML/AI into the design/build/test/learn cycle for synthetic biology projects. Here, we detail experimental methods, computational methods, and strategies for using CLASSIC to construct circuit libraries, acquire data sets, and train ML/AI models We highlight generalizable principles that can be applied to data-driven circuit design projects.
Indexed as
Identifiers
42420721What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.